Director, ADME, PK
Turning Point Therapeutics
Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. We are seeking a highly motivated individual to join Turning Point Therapeutics as a Director, ADME/PK . The Director of ADME/PK will be involved in the design, execution, analysis, interpretation and communication of nonclinical ADME/PK studies of small molecule and their associated delivery system to provide nonclinical ADME/PK profiles and risk assessment to support drug development. This position requires strong intellectual leadership, working at the interface of discovery and development teams and will serve as the nonclinical subject matter expert. The incumbent will design, conduct, and interpret nonclinical ADME/PK and investigational studies; will advise management on the pharmacokinetic aspects of the project and will effectively communicate with worldwide regulatory agencies to bring our drugs to patients as quickly as possible. This is an ideal position for an independent individual with a strong background in discovery and preclinical ADME/PK who enjoys working in a team-oriented and highly cross-disciplinary environment. Responsibilities:
|
Requirements:
EEO & Employment Eligibility TP Therapeutics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. TP Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. TP Therapeutics is an E-Verify employer. |
Principal Scientist, Enzymology DMPK | Groton, Connecticut |
Pfizer Inc. | 3 Weeks Ago |
Associate Director, Scientific Affairs | Princeton, New Jersey |
Novartis Pharma | 3 Weeks Ago |
Nonclinical Bioanalytical Scientist | San Diego, California |
Turning Point Therapeutics | 3 Weeks Ago |
Error